BRF
REVBW icon

B. Riley Financial’s Revelation Biosciences Warrant REVBW Stock Holding History

B. Riley Financial’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100,000
Closed -$1.62K – 35
2023
Q1 		$1.62K Buy
+100,000
New +$2.51K ﹤0.01% 46

Other funds holding REVBW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

B. Riley Financial's REVBW Position: Q2 2023 in Review

B. Riley Financial sold out of Revelation Biosciences Warrant (REVBW) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.62K sold.

B. Riley Financial first reported a position in REVBW in Q1 2023 and held it in 1 quarter. The position peaked at $1.62K in Q1 2023. 12 funds tracked by Wall St. Rank hold REVBW as of Q2 2023.

  • B. Riley Financial reported no remaining Revelation Biosciences Warrant position as of Q2 2023 after selling out during the quarter.
  • B. Riley Financial sold 100,000 Revelation Biosciences Warrant shares in Q2 2023, an estimated $1.62K.
  • B. Riley Financial first reported a position in Revelation Biosciences Warrant in Q1 2023 and held it in 1 quarter.
  • B. Riley Financial's Revelation Biosciences Warrant position peaked at $1.62K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2023.

Based on B. Riley Financial's 13F filing for Q2 2023, filed 8 Aug 2023.